Conversion of hIAPP into a soluble, noncytotoxic and bioactive analogue that inhibits hIAPP amyloidogenesis and cytotoxicity via a minimalistic peptide design strategy
- Publication date
- 1 January 2005
- Publisher
- 'Royal College of Obstetricians & Gynaecologists (RCOG)'
